Lilly’s Retatrutide Lowers A1C 2.2% at 80 Weeks in Type 2 Diabetes

Retatrutide lowered A1C by an average 2.2% at 80 weeks in adults with type 2 diabetes, versus 1.8% with Ozempic 2 mg.